MY01's sensor-based tool monitors limb perfusion and pressure in real-time, enabling early detection of acute injuries like compartment syndrome to prevent complications and limb loss.
Technology
MY01, a Canadian-based medical technology company, has developed an innovative sensor-based diagnostic tool designed to monitor limb perfusion and pressure in real-time, positioning it as a new vital sign for acute limb health. The technology involves a minimally invasive sensor inserted into the muscle (e.g., anterior muscle of the lower limb or volar compartment in the upper limb) via a simple introducer, comparable in complexity to an IV insertion. The sensor continuously tracks biomarkers, specifically pressure and perfusion, for up to 18 hours, the critical at-risk period for limb injuries. The device is supported by a connected system, including a mobile app and a cart with a screen for real-time data visualization, enabling coordinated care. MY01’s intellectual property is robust, with 50 patents covering sensor technology, device insertion methods, and data accuracy in complex anatomical environments. Prospective clinical studies involving 150 patients demonstrated 100% accuracy wh...
